Fig. 3From: The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathwaysa Representative flow cytometry results and hiPSC-EC differentiation efficiency when 1 μM U46619 was supplemented in differentiation stage 1, 2, or 3 (***p < 0.001 vs stage 1). Representative flow cytometry results and hiPSC-EC differentiation efficiency when U46619 was co-supplemented with Losma, SCH, or both Losma and SCH during differentiation stage 2 (b) or 3 (c) (***p < 0.001 vs any other treatment). Assessments of CD31 levels were compared with isotype controlsBack to article page